Ceva was founded in 1999 and has, for five years running, retained the title of being one of the top three fastest growing veterinary pharmaceutical companies in the world. With expertise in the livestock, poultry, swine and pet sectors, Ceva is constantly innovating to develop the most effective products for existing animal diseases, behavioural issues and animal productivity. Ceva is also largely invested in finding solutions to existing and emerging zoonoses (infectious diseases transmitted from wild or domestic animals and birds, to humans), including avian flu, chlamycliosis, brucellosis and Q-fever. Browse our range of Ceva pharmaceuticals, including bestsellers Adaptil and Feliway.
